ARIAD Pharma (ARIA) Closes 24.73M Offering; Nets ~$243M

ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) announced the completion of its previously announced public offering of 24,725,000 shares of common stock, including 3,225,000 shares issued pursuant to the underwriters’ exercise of their over-allotment option, at a public offering price of $10.42 per share, for total gross proceeds of approximately $258 million. Net proceeds to ARIAD from the offering are approximately $243 million after deducting underwriting discounts and commissions and estimated offering expenses.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
• ZeroStack (ZSTK) files for 54.61M share offering by selling stockholders
• Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders